February 2020 Clinical Watch Newsletter

March 4, 2020

In this issue of Clinical Watch, we discuss COVID-19 and suggest prior authorization criteria for immunotherapy to reduce the severity of allergic reactions to peanuts. Lastly, we review claims data for peanut allergy and use of epinephrine.


For more information about a specific topic, please contact Janelle Sheen or Karen Powell. Be sure to stay tuned for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Article
How Maven Helps Reduce the Spread of COVID-19
How Maven Helps Reduce the Spread of COVID-19

Next Article
Medicare three-day window payment policy holds strong
Medicare three-day window payment policy holds strong

Explore our Clinical Watch Newsletter

Learn More